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Abstract Mutations within the meaB gene elicit the inappropri- 
ate expression of several activities ubject to nitrogen metabolite 
repression in Aspergillus nidulans and also have some unrelated 
phenotypic effects. We have cloned meaB and isolated a full 
length cDNA clone. Northern analysis has shown that meaB 
expression is not subject o nitrogen metabolite repression, meaB 
encodes a novel protein of 418 amino acids and contains a 
significantly high number of SfFPXX motifs, a motif common in 
transcriptional regulatory proteins. We have sequenced three 
mutations within meaB, two of which have an identical phenotype 
to that produced by gene disruption. 
Key words: Nitrogen metabolite repression; meaB; areA; 
(Aspergillus nidulans) 
I. Introduction 
The utilisation of nitrogen sources in the environment by 
the filamentous fungus Aspergillus nidulans involves a strictly 
regulated and co-ordinated pattern of gene expression [1]. 
A. nidulans is capable of utilising a wide range of nitrogen 
containing compounds as sole nitrogen source, including am- 
monium, nitrate, nitrite, purines, amides and most amino 
acids. In the presence of ammonium or L-glutamine the ex- 
pression of those activities required for the uptake and utilisa- 
tion of other nitrogen sources is prevented, a phenomenon 
known as nitrogen metabolite repression [2-6]. Only in the 
absence of a repressing nitrogen source are the genes encoding 
these activities expressed [1]. 
Nitrogen metabolite repression is mediated by the activity 
of a positive trans-acting ene area [6,7]. Null mutants of 
areA are characterised by their inability to grow on nitrogen 
sources other than ammonium and L-glutamine [2,6]. The pro- 
duct of this gene, AREA, is a member of the GATA family of 
DNA binding proteins [8-10], capable of binding at promoter 
sequences containing the core motif -GATA- to direct gene 
expression [11,12]. areA activity is regulated, in response to 
the nitrogen state of the cell, by two independent mechanisms. 
The first mechanism involves the 3' UTR of the transcript, 
which affects AREA levels via transcript stability [13]. Disrup- 
tion of this region leads to increased transcript stability under 
repressed conditions and results in a partially derepressed 
phenotype characterised by the inappropriate xpression of 
activities normally subject o nitrogen metabolite repression. 
A similar phenotype results from either disruption of the last 
12 C-terminal amino acids or specific amino acid substitutions 
in the DNA binding domain, possibly via altered protein-pro- 
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tein interactions [13]. Glutamine appears to be the key meta- 
bolic effector in nitrogen metabolite repression [1]. 
In Neurospora crassa regulation of nitrogen metabolism is
achieved via the AREA homologue NIT2 [14,15], which is 
negatively regulated by NMR, the product of the negative 
regulatory gene nmr [16]. NMR interacts with the DNA bind- 
ing domain and C-terminus of NIT2 and this disrupts DNA 
binding in vitro. Disruption of nmr results in the general de- 
repression of activities ubject o nitrogen metabolite repres- 
sion within the cell, as does deletion of the C-terminal domain 
of nit-2 [17]. AREA and NIT2 show perfect conservation of 
their last nine amino acids, together with 98% identity over 
their DNA binding domains [9]. Since these two domains are 
important for both the NMR-NIT2 interaction [17] and cor- 
rect modulation of AREA function [13], AREA might well be 
regulated by an NMR-like protein in A. nidulans. Indeed, nit-2 
can complement an areA- phenotype, and shows partial reg- 
ulation [18]. 
Methylammonium can induce nitrogen metabolite repres- 
sion in the wild type and is toxic, its toxicity being reversed 
by ammonium and mutations increasing the conversion of the 
nitrogen source to ammonium [1,19,20]. Two mutations at a 
single locus, meaB6 and meaB20, were selected as conferring 
resistance to 100 mM methylammonium when 10 mM nitrate 
was provided as a nitrogen source, through derepression of 
nitrate reductase [6,19,21,22]. A third mutation at this locus, 
meaBlO0, was selected as a supressor of the areAr-130 muta- 
tion on nitrate and nitrite [5]. In addition to nitrate reductase, 
these mutations result in the derepression of a number of 
other activities ubject to nitrogen metabolite repression in- 
cluding nitrite reductase, xanthine dehydrogenase and urate 
oxidase [21]. 
The general nitrogen derepressed phenotypes of nmr- mu- 
tants and meaB- mutants, together with the similarity of ni- 
trogen metabolite repression in Neurospora and Aspergillus 
have given rise to speculation that nmr and meaB may be 
isofunctional and homologous [19]. However, meaB mutants 
also show additional pleiotropic effects [19] not seen in nmr 
mutants (Polley and Caddick unpublished). These effects in- 
clude reduced utilisation of L-arginine, L-aspartic acid, L-or- 
nithine, L-proline, and L-threonine as carbon sources by 
meaB6 strains, whilst all meaB mutations affect the toxicity 
of amino acid analogues. In complete medium meaB6 and 100 
mutants are resistant to p-fluorophenylalanine, whilst meaB20 
strains show variation in their phenotypes, according to the 
batch of complete medium used, ranging from hypersensitive 
to resistant, presumably in response to fluctuations in the 
phenylalanine content of the medium [19]. In minimal media 
meaB20 strains are hypersensitive to this analogue. All three 
mutations also result in hypersensitivity o nitrite toxicity 
which is non-additive to that caused by mutations at the 
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Fig. 1. meaB transcript levels during growth under derepressing and 
repressing nitrogen regimes in meaB6, -20  and -100 mutants and 
a meaB + strain. Total RNA was separated on a 1% denaturing for- 
maldehyde agarose gel and probed with meaB (A) and actin (B) 
specific probes. The size of the transcript was determined using 
Boehringer RNA molecular weight markers. Lanes: 1, meaB6 dere- 
pressed; 2, meaB20 derepressed; 3, meaBlO0 derepressed; 4, meaB6 
derepressed; 5, meaB + repressed; 6, meaB + derepressed. 
ninA locus [4]. Given that ninA probably affects nitrite efftux 
[5] one possible role for MEAB is that it affects the flow of 
metabolites across membranes, and possibly their compart- 
mentalisation within the cell [19]. Mutation of the meaB 
gene product could lead to altered gradients of metabolites 
within the cell, affecting protein synthesis and nitrogen meta- 
bolism within the cell. 
In this article we report the cloning and sequencing of meaB 
together with its characterisation at a molecular level, meaB 
encodes a novel protein product which is not homologous 
with NMR,  but might be a new transcription factor. 
2. Materials and methods 
2.1. Strains and growth conditions 
The following A. nidulans strains were derived from strains pro- 
vided by Arst [19]: pabaA1 (wild type), yA2 argB2 meaB6, yA2 
inoB2 meaB6, biA1, inoB2 meaB20, biA1 meaBlO0. Media and supple- 
ments used were those of Cove [23], whilst mycelial suspensions were 
grown overnight in liquid culture and assayed for nitrate reductase 
activity as described by Platt et al. [13]. 
2.2. General molecular genetic techniques 
Standard molecular techniques were performed as per Sambrook et 
al. [24]. A. nidulans total RNA was isolated according to the method 
of Sokolovsky et al. [25], whilst total genomic DNA was prepared as 
described by Raeder and Broda [26]. Transformation of A. nidulans 
with foreign DNA was performed using the method of Tilburn et al. 
[27]. Alkaline and northern transfers were performed using Zeta Probe 
(Bio-Rad) according to the manufacturers instructions, as were strin- 
gent hybridisation procedures. Bluescript (Stratgene) was used for 
subcloning, whilst pILJ16 [28], containing the argB gene, was used 
to complement argB2 in co-transformation experiments. 
Computer analysis of protein sequences was performed using the 
PROSITE program, whilst homology searches were performed using 
the TFASTA and BLITZ programs. All programs were made avail- 
able via the EBI. 
3. Results and discussion 
3.1. Cloning meaB 
The hypersensivity o nitrite toxicity of all meaB mutants 
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[19] formed the basis of our selection procedure. An A. nidu- 
lans total genomic osmid library [29], was screened to identi- 
fy cosmids capable of restoring rowth on 30 mM nitrite plus 
10 mM ammonium in a meaB6 strain. The library was or- 
dered into 33 pools of 8 clones, each clone specific to chromo- 
some III [29]. A single pool gave higher than background 
levels of colonies resistant to nitrite toxicity. Each of the eight 
clones from the pool were individually used to co-transform, 
together with pILJ 16, argB2 meaB6 strains, argB + transform- 
ants were selected and tested for meaB phenotype. A single 
cosmid W02 E01 restored wild-type growth at high frequency. 
W02 E01 was digested with a range of restriction endonu- 
cleases and the complete digests used for co-transformation 
in place of the intact cosmid. Digestion of the cosmid with 
KpnI, EcoRV,  BamHI  or XhoI did not prevent it from rescu- 
ing meaB + activity at a high frequency, indicating that none 
of these enzymes cuts within an esssential region of meaB, 
allowing it to function when inserted heterologously [30]. A 
single 5.2 kb KpnI fragment, capable of restoring meaB activ- 
ity at high level, was subcloned into Bluescript. cDNAs cross- 
hybridising to this region and capable of restoring meaB + 
activity were identified in a 24 h A. nidulans expression library 
constructed by Aramayo and Timberlake [31]. The cDNAs 
included a clone with an insert approx. 2 kb in size which 
northern analysis has shown to be the approximate size of 
the full length transcript (Fig. 1). This insert was fully se- 
quenced, together with several partial cDNA clones and the 
genomic copy. 
3.2. Sequence and predicted protein product o f  meaB 
The meaB transcript contains a single long open reading 
frame which extends through nucleotides +1 to 1698 (Fig. 2) 
and encodes a putative protein of 418 amino acids. The pu- 
tative initiation codon lies within a favourable initiation con- 
text (70% match to consensus equence TCACAATGGC)  
[32]. Within the transcribed region, just upstream of the pu- 
tative translation start site, lies an out of frame ATG situated 
in a far less favourable initiation context (only 40% identity to 
consensus equence), which does not fit the consensus e- 
quence identified as preventing downstream initiation ('leaky 
scanning') in A. nidulans [33]. Motif searches with the PRO- 
SITE program revealed no major functional structural motifs 
within the protein, although it does contain 12 potential phos- 
phorylation sites and four potential glycosylation sites. 
BLITZ searches of the SWISS-PROT database revealed 
26% identity with the largest subunit of RNA polymerase II
(RPBhI) of Arabidopsis over the protein's entire length. This 
region of identity maps mainly to the carboxy-terminal do- 
main (CTD) of RPBhI, a region composed of a heptapeptide 
Table 1 
Nitrate reductase activity in strains with different meaB alleles 
Allele Nitrogen derepressed Nitrogen repressed 
wild type 118 + 6 4 + 1 
meaB zx 86 _+ 10 23 _+ 3 
meaB6 83 + 5 25 + 4 
meaB20 89 + 10 18 + 2 
Cells were grown in liquid culture for 16 h at 37°C in inducing re- 
pressed (20 mM NO3, 40 mM NH +) or inducing derepressed (20 mM 
NO~-) conditions. Three replica trials were used for each condition, 
and three replica readings taken for each trial. Activities are given as 
nmol nitrite produced/min per mg soluble protein. 
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Fig. 2. Nucleotide sequence of meaB together with its flanking regions. The ATG translation start codon is labelled +1, whilst the predicted 
protein sequence is shown beneath the DNA sequence. Nucleotides of interest are denoted in bold lettering. Polyadenylation sites are sur- 
mounted by v*, whilst termination codons brought in line by the frame shift mutations are underlined, v01 marks the guanine deleted in 
meaBlO0 strains resulting in termination of the transcript at nucleotide 794. The frame shift results in the following novel sequence at the C- 
terminus after residue 128: ERPMARGNLVL. v 02 marks the adenine deleted in meaB6 strains resulting in termination of the transcript at 
nucleotide 1076. The frame shift results in the following novel sequence at the C-terminus after residue 161 : 
AASPPRSLSVFPSRAMVASVSRRPSFRLPLPPMSPHHRTPSHPTTGSRELCRLPVSILKHSGPKCSLTRET. ,703 marks the adenine deleted 
in meaBlO0 strains resulting in termination of the transcript at nucleotide 1500. The frame shift results in the following novel sequence at the 
C-terminus after residue 350: TMSRC. The BelI sites shown were used to construct pMB19. Introns and non-transcribed regions are listed in 
lower-case text whilst upper-case l tters denote the transcript. 
(YTPTSPK) repeat [34,35] and thought o be involved in reg- 
ulating the RNA polymerase II activity via specific localisa- 
tion of the protein to discrete subnuclear domains [36,37]. 
MEAB contains no repeats of this nature, and much of the 
residue identity results from the serine-rich sequences of the 
two proteins. There are, however, 11 S/TPXX motifs in 
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MEAB RKQRNRQAQADFRERRTEY I  RQLEST I K 
I il II It li li::ll l 
Cin5p RAAQN RSAQKAFRQ RREKY I KNLE EKS K 
Fig. 3. Sequence comparison of MEAB and Cin5p, a putative regu- 
latory protein in yeast. The two sequences show 45% identity and 
56% similarity over a 28 amino acid region. 
MEAB which have been identified as occurring at high fre- 
quency in transcriptional control proteins [38]. The frequency 
of S/TPXX motifs in MEAB is 26× 10 -3, which is compar- 
able to known regulatory proteins and far higher than that 
found in general proteins [38]. Random reassortmeut of the 
amino acid sequence of MEAB predicts that only six such 
sequences hould be found. A TFASTA search revealed 
45% identity to a 31 amino acid region of Cin5p (Fig. 3), a 
putative yeast regulatory protein (accession number 
u16780.gb_pl, Hoyt, M.A., unpublished). No specific function 
has been reported for this region of Cin5p. 
Pairwise alignment of MEAB and NMR has revealed no 
significant similarity, with the two proteins, showing at best 
only 17% identity over a 90 amino acid stretch. The number 
of S/TPXX motifs in the protein sequence together with its 
similarity to RPBhI and a putative yeast transcription factor 
Cin5p does raise the possibility that MEAB is actually a DNA 
binding protein, unlike NMR which binds directly with NIT2 
at the DNA binding domain and C-terminal domain [17]. 
Sequencing of five different cDNAs has revealed the exist- 
ence of at least three polyadenylation sites within the 3' region 
of the sequence, although there is an absence of the polyade- 
nylation signal AATAAA. This sequence, whilst common in 
higher eukaryotes, is absent from many filamentous fungal 
genes, and 3' transcript heterogeneity is also a common fea- 
ture of many fungal genes [32]. 
Comparison of the cDNA and genomic sequences revealed 
the existence of three introns; the first intron is 332 nucleo- 
tides which is unusually large for A. nidulans [32]. Elimination 
of all three introns by homologous intergration, using a par- 
tial meaB cDNA clone had no obvious effect on phenotype 
203 
(data not shown). It is therefore unlikely that any of the three 
introns have any overt functional significance. The 5' and 3' 
splice sites are well conserved, all three introns conforming to 
the consensus equence GTAY/AGTT/C and ACAG, respec- 
tively [32]. 
3.3. Expression of meaB 
Northern blot experiments have shown that meaB expres- 
sion is largely independent of nitrogen metabolite repression, 
yielding a single RNA transcript of approx. 2.0 kb (Fig. 1). 
The amount of meaB mRNA was relatively low, approx. 5% 
of the level of 7-actin mRNA [39], which is consistent with the 
very low codon bias of the gene. Total mRNA extracted from 
meaB- strains showed no change in the level or size of tran- 
script produced, suggesting that meaB is not autoregulated. 
3.4. Characterisation of meaB6, 20 and 100 mutations and 
deletion of the meaB gene 
Using the argB2 co-transformation system, internal PCR 
fragments of meaB were used to identify regions of the gene 
capable of restoring function in meaB6, 20 and 100 strains. A 
series of 300 bp PCR fragments was made, and three frag- 
ments identified as spanning the various mutations were am- 
plified from the respective mutant strains and sequenced. 
All three are frame shift mutations resulting from single 
base pair deletions, leading to truncation of the meaB product 
(Fig. 2). meaBlO0 and 6 cause translation to terminate at 
residues 140 and 233, respectively, whilst meaB20, which con- 
fers the weakest derepression of the three mutations, causes 
termination at residue 356. This proves that we have success- 
fully cloned meaB, and suggests that the N-terminal 356 res- 
idues retain some residual function. 
Deletion of meaB was achieved using the construct pMB19 
which contains a modified version of the 5.2 kb KpnI frag- 
ment identified in 3.1 cloned into Bluescript. A BclI digest was 
used to delete the meaB sequence between ucleotides -124 
and 1220 in this fragment (see Fig. 2). The deleted region 
includes the putative translation initiation codon. The argB2 
gene was amplified from the vector plLJ16 using primers with 
Kpn I EcoR I 
(A) 1 2 3 4 5 6 1 2 3 4 5 6 
5.2 kb  9.2 kb  
(a) 
m 
11.6 kb 
6.4 kb 
9.5 kb 
4.0 kb 
Fig. 4. Southern analysis of genomic DNA recovered from meaB mutants generated by gene disruption with pMB19. Sizes are indicated in kb. 
DNA was probed with a 300 bp segment of meaB contained entirely within the region deleted in pMB19 (A) and the argB gene (B). Lanes: l 
5, meaB mutants; 6, wild-type control. 
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A B C D E 
meaB6 
meaB20 
meaBlO0 
meaBA 
wild type 
Fig. 5. Phenotypic haracterisation f meaB mutants produced by 
gene disruption. Growth is shown after 48 h on minimal media 
plus: 10 mM NH + (A); 10 mM NH +, 100 mM C10~ (B); 10 mM 
NO~, 50 mM methylammonium (C); 10 mM NH +, 30 mM NO 2 
(D); and on complete medium plus 2 mg ml 1 DL-p-fluorophenylala- 
nine (E). 
flanking BamHI restriction sites, which were used to ligate the 
gene into the reconstituted BclI site. The new construct was 
linearised and used to transform an argB-  strain, argB ÷ 
meaB-  progeny were purified and characterised by Southern 
analysis (Fig. 4) to check for appropriate single copy integra- 
tion and gene replacement, before complete phenotypic 
analysis, meaBA strains show an identical phenotype to 
meaB6 and meaBlO0 mutants in both plate tests (Fig. 5) 
and nitrate reductase assays (Table 1), confirming that these 
two frame shift mutations are null mutations in meaB. 
4. Conclusion 
We have cloned and sequenced the meaB gene together with 
the three previously isolated mutations: meaB6, meaBlO0 and 
meaB20. The fact that MEAB and NMR are not homologous 
is consistent with the further pleiotropic effects conferred by 
the meaB mutations that are not seen in either N. crassa nmr-  
mutants or displayed by nitrogen metabolite derepressed areA 
mutants [19]. I f  MEAB and NMR were functionally equiva- 
lent, i.e. if the major function of MEAB were to negatively 
regulate AREA,  then meaB-  mutants should have phenotypes 
closely resembling rowth under derepressing conditions in- 
stead of the more pleiotropic phenotypes observed. 
Our derived sequence for the meaB product reveals a novel 
protein and does not refute the idea that MEAB affects cell 
compartmentalisation si ce the proposed sequence shows no 
convincing similarity to any known proteins and lacks any 
major structural motifs, other than S/TPXX. If  MEAB is a 
transcriptional regulatory protein, which would be consistent 
with the high frequency of S/TPXX motifs, then how such a 
DNA binding protein could act within the cell to affect proc- 
esses as diverse as amino acid uptake and/or metabolism, 
nitrite efflux and nitrogen metabolite repression is unclear. 
The activity of MEAB cannot be restricted to AREA how- 
ever, since null mutations in AREA are not fully epistatic to 
meaB-  mutations [19]. 
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